Steven Lester, MD
Cardiovascular Disease · Scottsdale, AZNPI 1790769966
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,535 of the $3,535 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Philips North America LLC.
Across 1 payment — averaging $3535.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$4K
Across 9 payments — averaging $36,983 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$333K
What the payments were for
- Consulting fees$3,535100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 1 | $3,535 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other$3,535
How this compares
$3,535 in reported general payments places this provider in the 60th percentile of 423 cardiovascular disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $17,406 |
| Metoprolol Succinate | 31 | $608 |
| Losartan Potassium | 29 | $379 |
| Warfarin Sodium | 21 | $368 |
| Rosuvastatin Calcium | 16 | $269 |
| Atorvastatin Calcium | 28 | $172 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Scottsdale
- Krishnaswami VijayaraghavanScottsdale$927K
- Paul UnderwoodScottsdale$259K
- Robert BurkeScottsdale$207K
- David RizikScottsdale$128K
- Martin CerdaScottsdale$66K
- Pattara RattanawongScottsdale$43K
- Mayank SardanaScottsdale$36K
- Ashish GuptaPhoenix$1.1M
- Rajkumar SugumaranPhoenix$957K
- Steven MottlTucson$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.